Development of a real-world evidence platform in NF2 to examine treatment patterns and outcomes
Neurofibromatosis type 2 (NF2) is a rare disease, and its low prevalence can make it challenging to conduct clinical research on long-term clinical outcomes of patients who use off-label therapies for management. See how AllStripes’ real-world data (RWD) platform can be used to understand disease burden and treatment patterns over time. This poster was presented at Children’s Tumor Foundation’s Neurofibromatosis Virtual Conference in June 2020.
Treatment Patterns for Depression and Anxiety Among Patients with Progressive Supranuclear Palsy (PSP)